Kanawha Capital Management LLC cut its position in shares of DuPont Co. (NYSE:DD) by 1.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 68,830 shares of the company’s stock after selling 750 shares during the period. Kanawha Capital Management LLC’s holdings in DuPont were worth $4,460,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Integrated Investment Consultants LLC raised its stake in shares of DuPont by 10.3% in the second quarter. Integrated Investment Consultants LLC now owns 2,050 shares of the company’s stock worth $133,000 after buying an additional 191 shares during the period. Signaturefd LLC raised its stake in shares of DuPont by 30.4% in the second quarter. Signaturefd LLC now owns 2,973 shares of the company’s stock worth $193,000 after buying an additional 693 shares during the period. CrestPoint Capital Management LLC acquired a new stake in shares of DuPont during the second quarter worth approximately $201,000. Ariel Capital Advisors LLC acquired a new stake in shares of DuPont during the second quarter worth approximately $201,000. Finally, Nicolet Bankshares Inc. acquired a new stake in shares of DuPont during the second quarter worth approximately $209,000. Institutional investors own 70.29% of the company’s stock.
DuPont Co. (NYSE:DD) traded up 1.12% during midday trading on Friday, hitting $68.90. The stock had a trading volume of 993,211 shares. DuPont Co. has a 1-year low of $50.71 and a 1-year high of $75.72. The company has a market capitalization of $60.24 billion, a PE ratio of 27.41 and a beta of 1.78. The stock’s 50-day moving average is $68.24 and its 200-day moving average is $66.82.
DuPont (NYSE:DD) last announced its earnings results on Tuesday, July 26th. The company reported $1.24 EPS for the quarter, topping the Zacks’ consensus estimate of $1.10 by $0.14. DuPont had a return on equity of 24.59% and a net margin of 9.01%. The company had revenue of $7.10 billion for the quarter, compared to analysts’ expectations of $7.01 billion. During the same period last year, the firm earned $1.18 EPS. DuPont’s revenue for the quarter was down .8% compared to the same quarter last year. Equities research analysts forecast that DuPont Co. will post $3.19 EPS for the current year.
A number of analysts have issued reports on DD shares. Vetr downgraded DuPont from a “buy” rating to a “hold” rating and set a $69.68 target price for the company. in a research report on Monday, June 20th. JPMorgan Chase & Co. downgraded DuPont from an “overweight” rating to a “neutral” rating and decreased their target price for the stock from $73.00 to $64.00 in a research report on Tuesday, June 28th. Zacks Investment Research downgraded DuPont from a “buy” rating to a “hold” rating in a research report on Tuesday, June 28th. Macquarie set a $71.00 target price on DuPont and gave the stock a “neutral” rating in a research report on Thursday, July 21st. Finally, Barclays PLC raised their target price on DuPont from $67.00 to $70.00 and gave the stock an “equal weight” rating in a research report on Wednesday, July 27th. Four research analysts have rated the stock with a sell rating, nine have issued a hold rating and six have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of $70.73.
In other DuPont news, SVP Benito Cachinero sold 58,958 shares of the stock in a transaction on Wednesday, August 24th. The stock was sold at an average price of $70.36, for a total value of $4,148,284.88. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Christopher Marc Doyle sold 5,422 shares of the stock in a transaction on Friday, August 26th. The stock was sold at an average price of $69.53, for a total value of $376,991.66. The disclosure for this sale can be found here. 0.31% of the stock is owned by corporate insiders.
DuPont Company Profile
E. I. du Pont de Nemours and Company (DuPont) is a science and technology-based company. The Company consists of over 10 businesses aggregated into six segments: Agriculture, Electronics & Communications, Industrial Biosciences, Nutrition & Health, Performance Materials and Safety & Protection. Its products include corn hybrids and soybean varieties, herbicides, fungicides and insecticides in Agriculture segment; photopolymers and electronic materials in Electronics & Communications segment; enzymes and bio-based materials in Industrial Biosciences segment; cultures, emulsifiers, texturants, natural sweeteners and soy-based food ingredients in Nutrition & Health segment; engineering polymers, packaging and industrial polymers, films and elastomers in Performance Materials segment, and nonwovens, aramids and solid surfaces in Safety & Protection segment.